Search Results - "Kovciń, V"

Disconnection of chamber and catheter as a complication of central venous catheter type port-a-cath by Kostic, S., Kovcin, V., Granić, M., Jevdic, D., Stanisavljevic, N.

“…The use of a central vein catheter (CVC) type port-a-cath(VPS), apart from the comfort it provides to the patient undergoing chemotherapy, also carries certain…”
Get full text

Biological and clinical features of non-Hodgkin's lymphoma in the elderly by Hajder, J, Marisavljevic, D, Stanisavljevic, N, Mihaljevic, B, Kovcin, V, Markovic, O, Zivkovic, R

“…The incidence of non-Hodgkin's lymphomas (NHLs) in elderly people has increased in recent years because the world population is getting older. The aim of this…”
Get more information

Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma by JELIC, S, KOVCIN, V, MILANOVIC, N, BABOVIC, N, KREACIC, M, RISTOVIC, Z, VLAJIC, M, FILIPOVIC-LJESKOVIC, I

“…A randomised study was started in chemotherapy-naive patients with advanced soft tissue sarcomas who received either epirubicin 60 mg/m 2/24 h (total dose for…”
Get full text

Comparison of the efficacy of two different dosage dacarbazine-based regimens and two regimens without dacarbazine in metastatic melanoma: a single-centre randomized four-arm study by Jelić, S, Babovic, N, Kovcin, V, Milicevic, N, Milanovic, N, Popov, I, Radosavljevic, D

“…The aim of this randomized four-arm phase III study was to evaluate whether there is a difference in activity between regimens containing dacarbazine and…”
Get full text

Gastric metastases of melanoma: two case reports by Kovcin, V, Josifovski, J, Opric, M

Get more information

Erlotinib as First-Line Treatment for Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Phase Iiib Study by Zaric, B., Perin, B., Cekic, M., Rancic, M., Kovcin, V., Andric, Z., Murtezani, Z.H., Jovanovic, D., Velinovic, M., Markovic, M.

Get full text

Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT) by Jelić, S., Kovčin, V., Milanović, N., Kreačić, M., Pendjer, I., Jovanović, V., Ristović, Z., Oprić, M., Mitrović, L.

“…Background The most active chemotherapy regimens in UCNT were those combining anthracyclines (doxorubicin or epirubicin) and cisplatin. Our previous pilot…”
Get full text

Serum gonadotropin levels in patients with germ-cell tumors of the testis: interrelations, possible cross-reactions and interpretation of beta-HCG level by Kovcin, V N, Jelić, S B, Ivanović, S M, Babović, N L

“…The concentration of FSH, LH, LTH, testosterone and beta-hCG was estimated in 177 serum samples from 86 patients with malignant germ-cell tumors of the testis…”
Get more information

Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study by Stojanovich, Ljudmila, Kontic, Milica, Djokovic, Aleksandra, Marisavljevic, Dragomir, Ilijevski, Nenad, Stanisavljevic, Natasa, Mikovic, Zeljko, Petkovic, Milena, Kovcin, Vladimir

“…The aim of this study was to investigate the importance of aPL type and level for non-criteria-related events in APS patients. Our study included 374 patients:…”
Get full text

Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia by Jelić, S, Jovanović, V, Milanović, N, Marinković, M, Kovcin, V, Milosević, D, Vlajić, M

“…The authors report seven cases of Richter's syndrome, i.e. of large-cell non-Hodgkin's lymphoma (NHL) arising in association with chronic lymphocytic leukemia…”
Get full text

A Two-Step Reevaluation of High-Dose Amsacrin for Advanced Carcinoma of the Upper Aerodigestive Tract: A pilot phase II study by Jelic, S., Nikolic-Tomasevic, Z., Kovcin, V., Milanovic, N., Tomasevic, Z., Jovanovic, V., Vlajic, M.

“…Results of amsacrine studies in different solid tumors with a dose of 85 mg/m 2 /24 h × 1 quo 3 weeks have been, in general, disappointing. Although only a few…”
Get full text

Primary gastric non-Hodgkin's lymphoma localized to the gastric wall: no adjuvant treatment following radical surgery by Jelić, S, Kovcin, V, Jovanović, V, Oprić, M, Milanović, N

“…The paper presents the experience with watch-and-wait policy following radical surgery in 25 patients with primary gastric non-Hodgkin's (NH) lymphoma…”
Get more information

Modulation of cisplatin antitumor activity by short infusional high-dose cytosine arabinoside in advanced pretreated head and neck carcinoma: a phase II study by Jelic, S, Mitrovic, L, Kovcin, V, Nikolic-Tomasevic, Z, Radulovic, S, Tomasevic, Z, Popov, I

“…The aim of the present study, which included 24 pretreated patients (both with radiotherapy and/or cisplatin-containing chemotherapy) with histological grade…”
Get more information

Non-IPSID small intestinal lymphoma: evidence for disseminated disease at presentation by MILANOVIC, N, JELIC, S, JOVANOVIC, V, KOVCIN, V, OPRIC, M, MARINKOVIC, M

“…During the period 1984-1989 the authors have observed 20 patients with non-IPSID small intestinal lymphomas, 11 males and 9 females. In 11 patients the first…”
Get full text

High-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma by Jelić, S, Vuletić, L, Milanović, N, Tomasević, Z, Kovcin, V

“…A chemotherapy regimen with epirubicin (60 mg/m2, days 1, 2 and 3) and cisplatin (30 mg/m2, days 2, 3, 4 and 5) was started for 35 patients with advanced soft…”
Get more information

EDTA clearance in monitoring cisplatin dose escalation in patients with bulky metastatic germ cell tumors of the testis by Jelić, S, Kovcin, V, Babović, N, Vuletić, L

“…A fast cisplatin clearance may reduce exposure time of tumor cells to the drug, and thus impair the expected effects of dose escalation. This hypothesis was…”
Get more information

The effect of interferon alfa-2b therapy on titers of isohemagglutinins and anti-Forssman antibodies in patients with malignant melanoma by Kovciń, V, Jelić, S, Pajević, M, Spuzić, I

“…According to experimental data, administration of interferon in mice before contact with antigen reduced antibody response, while its presence after antigen…”
Get more information

Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study by Jelić, Svetislav, Mitrović, Labuda, Radosavljević, Davorin, Elezar, Elizabeta, Babović, Nada, Kovčin, Vladimir, Tomašević, Zoran, Kovačević, Svetlana, Gavrilović, Dušica, Radulović, Siniša

“…This communication represents the definitive report of a randomized phase III study comparing cisplatin and carboplatin, in combination with vindesine and…”
Get full text

1068 Cisplatin 120mg/m2 vs. carboplatin 500mg/m2 in combination with mitomycin c and vindesin; a randomized phase III study in 164 patients with stage IIIB and IV squamous-cell bronhogenic carcinoma by Jelić, S., Mitrović, L., Radosavljević, D., Elezar, E., Kovćin, V., Ristović, Z., Kovacević, S., Radulović, S.

Get full text

224 Comparison of efficacy two different dose DTIC-based chemotherapy regimens and two non-DTIC based regimens in the treatment of metastatic malignant melanoma; study in 159 patients by Kovčin, V., Jelić, S., Mitrović, L., Radulović, S., Tomašević, Z., Milanovtć, N., Babović, N., Ristović, Z.

“…159 patients with disseminated malignant melanoma entered the four arm randomized study. Arm A: Adriamycin ADM 40 mg/m 2 day 1, BCNU 120 mg/m 2 and Vincristin…”
Get full text